Sky Century InvestmentSKYI -2.00%25 OCF Margin % is 4.65% as of Feb. 2026, which is 84% below its 10-year median of 29.31. GuruFocus rates SKYI with a GF Score™ of 25/100. The stock has 5 warning signs investors should review. Among 956 Drug Manufacturers companies, Sky Century Investment ranks better than 98.33% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sky Century Investment's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sky Century Investment OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sky Century Investment's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Sky Century Investment's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sky Century Investment (SKYI) has a OCF Margin % of 4.65% as of Feb. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sky Century Investment and its competitors. This is 84% below median its historical median of 29.31. According to the industry distribution chart, Sky Century Investment ranks #16 out of 956 companies in the Drug Manufacturers industry, placing it in the top 1.7%.
Is Sky Century Investment's OCF Margin % too high?
Sky Century Investment's current OCF Margin % of 4.65% is 84% below median its 10-year median of 29.31. The Drug Manufacturers industry median OCF Margin % is 9.99. Sky Century Investment's value of 4.65% is 53.4% below this industry median. Based on the distribution chart, Sky Century Investment ranks #16 out of 956 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sky Century Investment has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Sky Century Investment's OCF Margin % compare to IMCC and PLSH?
According to the Drug Manufacturers industry distribution chart, Sky Century Investment ranks #16 out of 956 companies for OCF Margin %. This places Sky Century Investment in the top 2% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.99. Sky Century Investment's value of 4.65% is 53.4% below this benchmark. While the company's 10-year median is 29.31 vs. the industry median of 9.99, Sky Century Investment has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.99, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sky Century Investment's current OCF Margin % of 4.65% is 53.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sky Century Investment and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sky Century Investment's current OCF Margin % is 4.65%, which is 84% below median its own 10-year median of 29.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sky Century Investment stock overvalued right now?
Sky Century Investment (SKYI) has a current OCF Margin % of 4.65%. The current OCF Margin % is 4.65%, which is 84% below median its 10-year median of 29.31 and 53.4% below the Drug Manufacturers industry median of 9.99. Sky Century Investment's overall GF Score™ is 25/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Sky Century Investment (SKYI), the current OCF Margin % is 4.65% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sky Century Investment Inc operates four primary business lines, with profits generated from IT Services, including Technical Support and Server Leasing, and from the sale of RSS feeds and Podcasts. The IT Services segment provides ongoing technical support, maintenance, system upgrades, and high-performance server leasing, supporting growing demand for cloud solutions, data management, and network infrastructure. The Company also owns the Cannabis News application, a mobile platform that aggregates cannabis-related news from diverse sources and delivers real-time updates, though it is not commercially viable and has not generated revenue to date. The Company operates in competitive markets across IT services, marketing services, RSS feed services, and the cannabis industry.
25GF Score
Get the complete analysis for SKYI
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SKYI has been successfully added to your 
